Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
0.4140
-0.0060 (-1.43%)
At close: Jul 15, 2025, 4:00 PM
0.4100
-0.0040 (-0.97%)
After-hours: Jul 15, 2025, 7:59 PM EDT
Rallybio Market Cap
Rallybio has a market cap or net worth of $17.23 million as of July 15, 2025. Its market cap has decreased by -71.92% in one year.
Market Cap
17.23M
Enterprise Value
-37.15M
1-Year Change
-71.92%
Ranking
Category
Stock Price
$0.41
Market Cap Chart
Since the IPO on July 29, 2021, Rallybio's market cap has decreased from $405.60M to $17.23M, a decrease of -95.75%. That is a compound annual growth rate of -54.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2025 | 17.23M | -56.74% |
| Dec 31, 2024 | 39.83M | -55.91% |
| Dec 29, 2023 | 90.33M | -63.67% |
| Dec 30, 2022 | 248.60M | -18.90% |
| Dec 31, 2021 | 306.52M | -24.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 712.69B |
| Johnson & Johnson | 376.72B |
| AbbVie | 337.26B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 272.36B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 230.48B |
| AstraZeneca | 218.74B |